Tissue-resident macrophages ? how to humanize our knowledge, Immunol Cell Biol, vol.95, pp.173-177, 2017. ,
Origin and Functions of Tissue Macrophages, Immunity, vol.41, issue.1, pp.21-35, 2014. ,
DOI : 10.1016/j.immuni.2014.06.013
The development and maintenance of resident macrophages, Nature Immunology, vol.14, issue.1, pp.2-8, 2016. ,
DOI : 10.1038/ni.2622
Tissue biology perspective on macrophages, Nature Immunology, vol.195, issue.1, pp.9-17, 2016. ,
DOI : 10.1084/jem.20001858
Exploring the full spectrum of macrophage activation, Nature Reviews Immunology, vol.117, issue.12, pp.958-969, 2008. ,
DOI : 10.4049/jimmunol.171.7.3550
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation, Immunity, vol.40, issue.2, pp.274-288, 2014. ,
DOI : 10.1016/j.immuni.2014.01.006
Macrophage plasticity and polarization: in vivo veritas, Journal of Clinical Investigation, vol.122, issue.3, pp.787-795, 2012. ,
DOI : 10.1172/JCI59643DS1
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nature Immunology, vol.313, issue.10, pp.889-896, 2010. ,
DOI : 10.1016/j.ccr.2009.06.017
Macrophage-mediated inflammation in metabolic disease, Nature Reviews Immunology, vol.17, issue.11, pp.738-749, 2011. ,
DOI : 10.1038/nm.2353
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends in Immunology, vol.23, issue.11, pp.549-555, 2002. ,
DOI : 10.1016/S1471-4906(02)02302-5
Macrophage activation and polarization, Frontiers in Bioscience, vol.13, issue.13, pp.453-461, 2008. ,
DOI : 10.2741/2692
Tumour-associated macrophages as treatment targets in oncology, Nature Reviews Clinical Oncology, vol.17, issue.7, pp.399-416, 2017. ,
DOI : 10.1038/ni.3354
The prognostic landscape of genes and infiltrating immune cells across human cancers, Nature Medicine, vol.30, issue.8, pp.938-945, 2015. ,
DOI : 10.18637/jss.v030.i10
Tumor-Associated Macrophages: From Mechanisms to Therapy, Immunity, vol.41, issue.1, pp.49-61, 2014. ,
DOI : 10.1016/j.immuni.2014.06.010
URL : https://doi.org/10.1016/j.immuni.2014.09.021
Macrophages and cancer: from mechanisms to therapeutic implications, Trends in Immunology, vol.36, issue.4, pp.229-239, 2015. ,
DOI : 10.1016/j.it.2015.02.004
Tumorassociated macrophages: unwitting accomplices in breast cancer malignancy, NPJ Breast Cancer, vol.2, 2016. ,
Macrophage Polarization, Annual Review of Physiology, vol.79, issue.1, pp.541-566, 2017. ,
DOI : 10.1146/annurev-physiol-022516-034339
An Immune Atlas of Clear Cell Renal Cell Carcinoma, Cell, vol.169, issue.4, pp.736-749, 2017. ,
DOI : 10.1016/j.cell.2017.04.016
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid, Nature, vol.88, issue.7519, pp.559-563, 2014. ,
DOI : 10.1016/S0092-8674(00)81848-6
Colony-stimulating factors in inflammation and autoimmunity, Nature Reviews Immunology, vol.39, issue.7, pp.533-544, 2008. ,
DOI : 10.1161/01.ATV.19.1.98
Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases, Nature Reviews Drug Discovery, vol.15, issue.1, pp.53-70, 2016. ,
DOI : 10.1006/cyto.2001.0937
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects, Blood, vol.99, issue.1, pp.111-120, 2002. ,
DOI : 10.1182/blood.V99.1.111
The Colony-Stimulating Factor 1 Receptor Is Expressed on Dendritic Cells during Differentiation and Regulates Their Expansion, The Journal of Immunology, vol.175, issue.3, pp.1399-1405, 2005. ,
DOI : 10.4049/jimmunol.175.3.1399
Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits, PLoS One, vol.6, 2011. ,
Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome, Science, vol.2, issue.1, pp.807-811, 2008. ,
DOI : 10.1182/blood.V99.1.111
Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor, Curr Top Dev Biol, vol.123, pp.229-275, 2017. ,
DOI : 10.1016/bs.ctdb.2016.10.004
Pleiotropic effects of extended blockade of CSF1R signaling in adult mice, Journal of Leukocyte Biology, vol.96, issue.2, pp.265-274, 2014. ,
DOI : 10.1189/jlb.2A0114-006R
Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models, The Journal of Immunology, vol.188, issue.11, pp.5752-5765, 2012. ,
DOI : 10.4049/jimmunol.1103426
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences, Blood, vol.121, pp.57-69, 2013. ,
Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways, The Journal of Immunology, vol.195, issue.5, pp.2442-2451, 2015. ,
DOI : 10.4049/jimmunol.1403045
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells, Blood, vol.110, issue.13, pp.4319-4330, 2007. ,
DOI : 10.1182/blood-2007-02-072587
URL : http://www.bloodjournal.org/content/bloodjournal/110/13/4319.full.pdf
IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1??, European Journal of Immunology, vol.38, issue.4, pp.1092-1102, 2015. ,
DOI : 10.1002/eji.200838535
URL : https://hal.archives-ouvertes.fr/hal-01392241
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages, European Journal of Immunology, vol.107, issue.6, pp.1618-1626, 2012. ,
DOI : 10.1182/blood-2005-07-2696
IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells, Hepatology, vol.176, issue.1, pp.1879-1890, 2014. ,
DOI : 10.1164/rccm.200609-1279OC
The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer, Cancer Res, vol.54, pp.5455-5463, 1994. ,
The roles of TGF?? in the tumour microenvironment, Nature Reviews Cancer, vol.191, issue.11, pp.788-799, 2013. ,
DOI : 10.1084/jem.191.7.1187
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments, Frontiers in Oncology, vol.173, issue.Suppl 1, 2016. ,
DOI : 10.2353/ajpath.2008.080380
Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction, International Journal of Molecular Medicine, vol.35, issue.1, pp.92-102, 2015. ,
DOI : 10.3892/ijmm.2014.2001
CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation, Gastroenterology J Exp Med, vol.149, issue.208, pp.1896-1909, 2011. ,
Macrophages in Tissue Repair, Regeneration, and Fibrosis, Immunity, vol.44, issue.3, pp.450-462, 2016. ,
DOI : 10.1016/j.immuni.2016.02.015
Differential Roles of Macrophages in Diverse Phases of Skin Repair, The Journal of Immunology, vol.184, issue.7, pp.3964-3977, 2010. ,
DOI : 10.4049/jimmunol.0903356
Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages, Nature Communications, vol.0171, issue.2985, p.5444, 2014. ,
DOI : 10.1002/art.24406
URL : http://www.nature.com/articles/ncomms6444.pdf
Role of CSF-1 in progression of epithelial ovarian cancer, Future Oncology, vol.111, issue.9, pp.1429-1440, 2009. ,
DOI : 10.1016/j.ygyno.2008.06.028
High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma, Journal of Clinical Oncology, vol.26, issue.16, pp.2707-2716, 2008. ,
DOI : 10.1200/JCO.2007.15.6521
High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma, Annals of Surgical Oncology, vol.41, issue.21, pp.1044-1052, 2016. ,
DOI : 10.1016/j.ctrv.2014.12.013
Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma, BMC Cancer, vol.115, issue.10, p.67, 2015. ,
DOI : 10.1002/cncr.24263
CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma, American Journal of Clinical Pathology, vol.141, issue.4, pp.573-583, 2014. ,
DOI : 10.1309/AJCPR92TDDFARISU
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy, The Journal of Experimental Medicine, vol.112, issue.6, pp.727-740, 2001. ,
DOI : 10.1038/sj.onc.1201869
Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development, Oncogene, vol.345, issue.11, pp.1459-1467, 2012. ,
DOI : 10.1038/345442a0
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer, Cancer Research, vol.66, issue.23, pp.11238-11246, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-1278
Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer, Biochemical Society Transactions, vol.44, issue.2, pp.333-341, 2016. ,
DOI : 10.1042/BST20150245
Effects of GM-CSF and M-CSF on tumor progression of lung cancer: Roles of MEK1/ERK and AKT/PKB pathways, International Journal of Molecular Medicine, vol.18, pp.365-373, 2006. ,
DOI : 10.3892/ijmm.18.2.365
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones?, Journal of Clinical & Cellular Immunology, vol.06, issue.06, 2015. ,
DOI : 10.4172/2155-9899.1000379
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy, Cancer Cell, vol.25, issue.6, pp.846-859, 2014. ,
DOI : 10.1016/j.ccr.2014.05.016
Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer, Cancer Research, vol.75, issue.22, pp.4742-4752, 2015. ,
DOI : 10.1158/0008-5472.CAN-14-3373
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumorassociated macrophages and enhancing infiltration by CD8+ T cells CSF-1R inhibition alters macrophage polarization and blocks glioma progression, Nat Med, vol.19, pp.1264-1272, 2013. ,
Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization, Neuro-Oncology, vol.109, issue.(4), pp.797-806, 2016. ,
DOI : 10.1016/j.cell.2013.03.010
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy, Cancer Research, vol.74, issue.1, pp.153-161, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-1816
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition, BMC Cancer, vol.3, issue.7287, p.356, 2015. ,
DOI : 10.1038/ncomms1727
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase, Oncogene, vol.46, issue.29, pp.3812-3819, 2014. ,
DOI : 10.1038/nature11249
CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy, Cancer Research, vol.75, issue.6, pp.950-962, 2015. ,
DOI : 10.1158/0008-5472.CAN-14-0992
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy, Cancer Discovery, vol.1, issue.1, pp.54-67, 2011. ,
DOI : 10.1158/2159-8274.CD-10-0028
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models, Cancer Research, vol.74, issue.18, pp.5057-5069, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-3723
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study, J Immunother Cancer Lancet Oncol, vol.5, issue.16, pp.949-956, 2015. ,
IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation, Cell Death & Differentiation, vol.145, issue.12, pp.1917-1927, 2010. ,
DOI : 10.1093/nar/22.22.4673
Syndecan-1 regulates the biological activities of interleukin-34, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1853, issue.5, pp.1010-1021, 2015. ,
DOI : 10.1016/j.bbamcr.2015.01.023
URL : https://hal.archives-ouvertes.fr/inserm-01644783
The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation, Developmental Biology, vol.367, issue.2, pp.100-113, 2012. ,
DOI : 10.1016/j.ydbio.2012.03.026
IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia, Nature Immunology, vol.165, issue.8, pp.753-760, 2012. ,
DOI : 10.1016/j.immuni.2011.06.005
IL-34 is a Treg-specific cytokine and mediates transplant tolerance, J Clin Invest, vol.125, pp.3952-3964, 2015. ,
Immunoregulatory properties of the cytokine IL-34, Cellular and Molecular Life Sciences, vol.6, issue.1, pp.2569-2586, 2017. ,
DOI : 10.3892/ijmm.2014.2001
Activation of the Interleukin-34 Inflammatory Pathway in Response to Influenza A Virus Infection, The American Journal of the Medical Sciences, vol.349, issue.2, pp.145-150, 2015. ,
DOI : 10.1097/MAJ.0000000000000373
Interleukin 34: a new modulator of human and experimental inflammatory bowel disease, Clinical Science, vol.91, issue.3, pp.281-290, 2015. ,
DOI : 10.1073/pnas.0405979102
Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy, Int J Clin Exp Med, vol.8, pp.7809-7815, 2015. ,
Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus, Molecules, vol.22, issue.12, p.35, 2016. ,
DOI : 10.1002/art.1780400928
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes, Rheumatology, vol.68, issue.3, pp.1009-1017, 2013. ,
DOI : 10.1136/ard.2008.087874
Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo, PLOS ONE, vol.8, issue.10, 2017. ,
DOI : 10.1371/journal.pone.0179605.t002
IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFN??, PLoS ONE, vol.145, issue.2, p.56045, 2013. ,
DOI : 10.1371/journal.pone.0056045.s004
Interferon-?? reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages, International Journal of Cancer, vol.21, issue.2, pp.367-373, 2009. ,
DOI : 10.4049/jimmunol.168.2.689
miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis, Hepatology, vol.25, issue.5, pp.1560-1575, 2016. ,
DOI : 10.1200/JCO.2006.09.4565
URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.28445/pdf
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells, Cancer Research, vol.76, issue.20, pp.6030-6042, 2016. ,
DOI : 10.1158/0008-5472.CAN-16-1170
Regulation of macrophage development and function in peripheral tissues, Nature Reviews Immunology, vol.510, issue.12, pp.731-744, 2015. ,
DOI : 10.1038/ni.2967
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF, The Journal of Experimental Medicine, vol.280, issue.10, 1977. ,
DOI : 10.1089/hum.1998.9.14-2101
GM-CSF: a role in immune and inflammatory reactions in the intestine, Expert Review of Gastroenterology & Hepatology, vol.4, issue.6, pp.723-731, 2010. ,
DOI : 10.1378/chest.08-2943
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy, Journal of Interferon & Cytokine Research, vol.35, issue.8, pp.585-599, 2015. ,
DOI : 10.1089/jir.2014.0149
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation, Immunity, vol.45, issue.5, pp.963-973, 2016. ,
DOI : 10.1016/j.immuni.2016.10.026
Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.168, issue.(Suppl 2), pp.899-907, 2016. ,
DOI : 10.4049/jimmunol.168.10.5333
Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis, Arthritis & Rheumatism, vol.14, issue.8, pp.2340-2351, 2011. ,
DOI : 10.1016/0167-5699(93)90319-G
Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation, Clinical and Experimental Immunology, vol.139, issue.2, pp.361-367, 2000. ,
DOI : 10.3109/08977199309010831
Protection from collageninduced arthritis in granulocyte-macrophage colonystimulating factor-deficient mice, J Immunol, vol.161, pp.3639-3644, 1998. ,
GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice, Annals of the Rheumatic Diseases, vol.66, issue.4, pp.452-457, 2007. ,
DOI : 10.1136/ard.2006.057182
The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF, Nature Immunology, vol.18, issue.6, pp.568-575, 2011. ,
DOI : 10.1016/S0022-510X(03)00203-X
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells, Science Translational Medicine, vol.15, issue.9, pp.241-280, 2014. ,
DOI : 10.1038/nbt0997-871
Targeting the GM-CSF receptor for the treatment of CNS autoimmunity, Journal of Autoimmunity, vol.84, pp.1-11, 2017. ,
DOI : 10.1016/j.jaut.2017.06.005
Granulocyte-Macrophage Colony-Stimulating Factor (CSF) and Macrophage CSF-Dependent Macrophage Phenotypes Display Differences in Cytokine Profiles and Transcription Factor Activities: Implications for CSF Blockade in Inflammation, The Journal of Immunology, vol.178, issue.8, pp.5245-5252, 2007. ,
DOI : 10.4049/jimmunol.178.8.5245
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria, Proceedings of the National Academy of Sciences, vol.99, issue.3, pp.4560-4565, 2004. ,
DOI : 10.1073/pnas.022649799
URL : http://www.pnas.org/content/101/13/4560.full.pdf
Human dendritic cell subsets in vaccination, Current Opinion in Immunology, vol.25, issue.3, pp.396-402, 2013. ,
DOI : 10.1016/j.coi.2013.05.001
Dendritic-Cell-Based Therapeutic Cancer Vaccines, Immunity, vol.39, issue.1, pp.38-48, 2013. ,
DOI : 10.1016/j.immuni.2013.07.004
URL : https://doi.org/10.1016/j.immuni.2013.07.004
GM-CSF Controls Nonlymphoid Tissue Dendritic Cell Homeostasis but Is Dispensable for the Differentiation of Inflammatory Dendritic Cells, Immunity, vol.36, issue.6, pp.1031-1046, 2012. ,
DOI : 10.1016/j.immuni.2012.03.027
Recent progress in GM-CSF-based cancer immunotherapy, Immunotherapy, vol.31, issue.18, pp.347-360, 2017. ,
DOI : 10.1172/JCI81083
Vaccination With Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor Augments Antitumor Immunity in Some Patients With Metastatic Non???Small-Cell Lung Carcinoma, Journal of Clinical Oncology, vol.21, issue.4, pp.624-630, 2003. ,
DOI : 10.1200/JCO.2003.03.091
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types, Experimental & Molecular Medicine, vol.16, issue.1074, p.242, 2016. ,
DOI : 10.1158/1078-0432.CCR-09-1800
Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma, Journal of Clinical Oncology, vol.21, issue.17, pp.3343-3350, 2003. ,
DOI : 10.1200/JCO.2003.07.005
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocytemacrophage colony-stimulating factor using ex vivo gene transfer, Cancer Res, vol.59, pp.5160-5168, 1999. ,
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity, Cytokine, vol.75, issue.2, pp.261-271, 2015. ,
DOI : 10.1016/j.cyto.2015.05.030
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553090/pdf
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer, Cancer Cell, vol.21, issue.6, pp.822-835, 2012. ,
DOI : 10.1016/j.ccr.2012.04.025
Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia, Cancer Cell, vol.21, issue.6, pp.836-847, 2012. ,
DOI : 10.1016/j.ccr.2012.04.024
Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors, Cancer Research, vol.73, issue.1, pp.395-405, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-0806
Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma, Blood, vol.95, pp.270-276, 2000. ,
Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin, Tumor Biology, vol.19, issue.5, 2017. ,
DOI : 10.1080/15257770008033036
URL : http://journals.sagepub.com/doi/pdf/10.1177/1010428317699797
The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis, IUBMB Life, vol.282, issue.Suppl 1, pp.611-617, 2010. ,
DOI : 10.1172/JCI17085
Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in na??ve T cells, European Journal of Immunology, vol.116, issue.11, pp.3097-3106, 2010. ,
DOI : 10.4049/jimmunol.166.9.5530
Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-??, European Journal of Immunology, vol.34, issue.5, pp.1291-1302, 2004. ,
DOI : 10.1002/eji.200324651
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells, Blood, vol.95, pp.2484-2490, 2000. ,
Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance, Blood, vol.103, issue.9, pp.3573-3581, 2004. ,
DOI : 10.1182/blood-2003-08-2864
An Open-Label Pilot Study of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Endoscopic Postoperative Recurrence in Crohn???s Disease, Digestion, vol.68, issue.2-3, pp.63-70, 2003. ,
DOI : 10.1159/000074517
G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versushost disease, Sci Transl Med, vol.7, pp.281-242, 2015. ,
Jagged2-Expressing Hematopoietic Progenitors Promote Regulatory T Cell Expansion in the Periphery through Notch Signaling, Immunity, vol.25, issue.5, pp.823-834, 2006. ,
DOI : 10.1016/j.immuni.2006.09.008
Treatment With Granulocyte Colony-Stimulating Factor Prevents Diabetes in NOD Mice by Recruiting Plasmacytoid Dendritic Cells and Functional CD4+CD25+ Regulatory T-Cells, Diabetes, vol.54, issue.1, pp.78-84, 2005. ,
DOI : 10.2337/diabetes.54.1.78
Granulocyte colony-stimulating factor treatment ameliorates lupus nephritis through the expansion of regulatory T cells, BMC Nephrology, vol.67, issue.7, p.175, 2016. ,
DOI : 10.1136/ard.2007.083543
Elevated Interleukin-6 and G-CSF in Human Pancreatic Cancer Cell Conditioned Medium Suppress Dendritic Cell Differentiation and Activation, Cancer Research, vol.67, issue.11, pp.5479-5488, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-3963
G-CSF receptor expression in ovarian cancer, International Journal of Gynecological Cancer, vol.10, issue.1, pp.19-26, 2000. ,
DOI : 10.1046/j.1525-1438.2000.99076.x
Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells, International Journal of Cancer, vol.58, issue.1, pp.42-46, 2001. ,
DOI : 10.1002/(SICI)1096-9896(199909)189:1<40::AID-PATH405>3.0.CO;2-#
G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration, British Journal of Cancer, vol.4, issue.5, pp.1211-1220, 2014. ,
DOI : 10.1007/s10120-005-0335-6
CD114 expression mediates melanoma tumor cell growth and treatment resistance, Anticancer Res, vol.35, pp.3787-3792, 2015. ,
G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic, Cancer Research, vol.73, issue.13, pp.4134-4146, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-4056
CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family, Journal of Cellular Biochemistry, vol.35, issue.2, pp.221-231, 2017. ,
DOI : 10.1038/srep17663
G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer, 2016. ,
Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses, Oncotarget, vol.6, issue.26, pp.22338-22347, 2015. ,
DOI : 10.18632/oncotarget.4169
Critical role for granulocyte colony-stimulating factor in inflammatory arthritis, Proceedings of the National Academy of Sciences, vol.48, issue.11, pp.11398-11403, 2004. ,
DOI : 10.1002/art.11301
The colony-stimulating factors and collageninduced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF, 2000. ,
Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages, Blood, vol.101, issue.1, pp.143-150, 2003. ,
DOI : 10.1182/blood-2002-04-1164
URL : http://www.bloodjournal.org/content/bloodjournal/101/1/143.full.pdf
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages, Nature Immunology, vol.80, issue.6, pp.510-514, 2000. ,
DOI : 10.1016/0092-8674(95)90418-2
A Critical Role for Stat3 Signaling in Immune Tolerance, Immunity, vol.19, issue.3, pp.425-436, 2003. ,
DOI : 10.1016/S1074-7613(03)00232-2
Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors Altered macrophage differentiation and immune dysfunction in tumor development, J Immunol J Clin Invest, vol.187, issue.117, pp.27-36, 2007. ,
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity, Nature Medicine, vol.187, issue.12, pp.1314-1321, 2005. ,
DOI : 10.1084/jem.187.11.1753
Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation, Cancer Science, vol.114, issue.10, pp.2128-2136, 2010. ,
DOI : 10.1093/jnci/94.8.617
Transcriptional mechanisms that control expression of the macrophage colony-stimulating factor receptor locus, Clinical Science, vol.131, issue.16, pp.2161-2182, 2017. ,
DOI : 10.1042/CS20170238
TNF-??-Converting Enzyme Cleaves the Macrophage Colony-Stimulating Factor Receptor in Macrophages Undergoing Activation, The Journal of Immunology, vol.166, issue.3, pp.1583-1589, 2001. ,
DOI : 10.4049/jimmunol.166.3.1583
Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: Implication in atherosclerosis, Atherosclerosis, vol.214, issue.2, pp.316-324, 2011. ,
DOI : 10.1016/j.atherosclerosis.2010.11.023
Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF, Cell, vol.63, issue.5, pp.1073-1083, 1990. ,
DOI : 10.1016/0092-8674(90)90510-L
A GM-colony-stimulating factor (CSF) activated ribonuclease system transregulates M-CSF receptor expression in the murine FDC-P1/MAC myeloid cell line., Molecular Biology of the Cell, vol.3, issue.5, pp.535-544, 1992. ,
DOI : 10.1091/mbc.3.5.535
The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor, Cancer Immunology Research, vol.2, issue.8, pp.765-776, 2014. ,
DOI : 10.1158/2326-6066.CIR-13-0190
The interaction of anticancer therapies with tumor-associated macrophages, The Journal of Experimental Medicine, vol.14, issue.4, pp.435-445, 2015. ,
DOI : 10.1158/1078-0432.CCR-10-1343
Macrophages are critical effectors of antibody therapies for cancer, mAbs, vol.13, issue.2, pp.303-310, 2015. ,
DOI : 10.1073/pnas.1305569110
Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer, Cancer Research, vol.75, issue.23, pp.5008-5013, 2015. ,
DOI : 10.1158/0008-5472.CAN-15-1330
M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro, The Journal of Immunology, vol.182, issue.7, pp.4415-4422, 2009. ,
DOI : 10.4049/jimmunol.0713732
Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro, International Journal of Oncology, vol.38, issue.5, pp.1409-1419, 2011. ,
DOI : 10.3892/ijo.2011.960
MicroRNAmediated down-regulation of M-CSF receptor contributes to maturation of mouse monocyte-derived dendritic cells, Front Immunol, vol.4, p.353, 2013. ,
Dendritic Cell Generation from Highly Purified CD14<sup>+</sup> Monocytes, Methods Mol Med, vol.64, pp.283-296, 2001. ,
DOI : 10.1385/1-59259-150-7:283
The chemokine system in diverse forms of macrophage activation and polarization, Trends in Immunology, vol.25, issue.12, pp.677-686, 2004. ,
DOI : 10.1016/j.it.2004.09.015
A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas, J Immunol, vol.144, pp.2409-2412, 1990. ,
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome, Breast Cancer Research and Treatment, vol.24, issue.3, pp.703-711, 2011. ,
DOI : 10.1200/JCO.2005.04.5518
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657137/pdf